Kirsten Ahring
PKU Department
The Kennedy Centre
Bagsvaerd, Denmark
Jean-Daniel Baki
Board of Directors
Serono Symposia International Foundation
Geneva, Switzerland
Amaya Bélanger-Quintana
Unidad de enfermedades metabolicas
Servicio de Pediatria
Hospital Ramon y Cajal
Madrid, Spain
Anne Daly
Dietetic Department
Birmingham Children’s Hospital
Birmingham, UK
Hulya Gokmen-Ozel
Faculty of Health Sciences - Department of Nutrition and Dietetics
Hacettepe University
Ankara, Turkey
Annamaria Lammardo
Department of Pediatrics
San Paolo Hospital University of Milan
Milan, Italy
Anita MacDonald
Dietetic Department
The Children’s Hospital
Birmingham, UK
Kristina Motzfeldt
Department of Pediatric Research
Rikshospitalet University Hospital
Oslo, Norway
Martine Robert
Hôpital Universitaire des Enfants - Reine-Fabiola
Brussels, Belgium
Margreet van Rijn
Section of Metabolic Diseases
Beatrix Children's Hospital
University Medical Center Groningen
Groningen, Netherlands
Eleanor Weetch
Nutrition and Dietetics
National Society for Phenylketonuria UK and Adult Metabolic Dietitian
Northern General Hospital, Sheffield
Barnsley, South Yorkshire, UK
Heidi Zweers
Department of Gastroenterology and Hepatology-Dietetics
Radboud University Nijmegen Medical Centre
Nijmegen, Netherlands
Serono Symposia International Foundation adheres to guidelines of the European Accreditation Council for Continuing Medical Education (EACCME) and all other professional organizations, as applicable, which state that programs awarding continuing education credits must be balanced, independent, objective, and scientifically rigorous. Investigative and other uses for pharmaceutical agents, medical devices, and other products (other than those uses indicated in approved product labeling/package insert for the product) may be presented in the program (which may reflect clinical experience, the professional literature or other clinical sources known to the presenter). We ask all presenters to provide participants with information about relationships with pharmaceutical or medical equipment companies that may have relevance to their lectures. This policy is not intended to exclude faculty who have relationships with such companies; it is only intended to inform participants of any potential conflicts so participants may form their own judgments, based on full disclosure of the facts. Further, all opinions and recommendations presented during the program and all program-related materials neither imply an endorsement, nor a recommendation, on the part of Serono Symposia International Foundation. All presentations solely represent the independent views of the presenters/authors.
The following faculty provided information regarding significant commercial relationships and/or discussions of investigational or non-EMEA/FDA approved (off-label) uses of drugs:
Kirsten Ahring Declared to be member of the European Nutritionist Expert Panel (ENEP).
Amaya Bélanger-Quintana Declared receipt of honoraria or consultation fees from Mead Johnson, SHS and Cassen and to bemember of Merck Serono PKU advisory board, Nutritional expert panel and Kamper advisory board.
Anne Daly Declared to be member of the advisory boards of BIMDG and NSPKU (non-profit organization).
Hulya Gokmen-Ozel Declared to be member of ENEP Group.
Annamaria Lammardo Declared receipt of grants and contracts from Merck Serono as ENEP Group member.
Anita MacDonald Declared receipt of research grant/posts from Nutricia and Vitaflo, of honoraria from Nutricia, Vitaflo and Merck Serono, member of Sapropterin PKU Advisory Board; Chair of ENEP; and Member of Nutricia
Advisory Board for IMD.
Kristina Motzfeldt Declared to be member of ENEP, European Nutritional Expert Panel in PKU, sponsored by Merck Serono and to be sponsored by SHS International for travelling expenses to a meeting in Metabolic in April
2011 in London (UK).
Martine Robert Declared no potential conflict of interest.
Júlio César Rocha Declared participation at the Merck Serono’s Satellite Symposium – SSIEM 2010 and to be member ofthe European Nutritionist Expert Panel – Merck Serono.
Yvonne Rogers Declared no potential conflict of interest.
Margreet van Rijn Declared no potential conflict of interest.
Eleanor Weetch Declared no potential conflict of interest.
Heidi Zweers Declared no potential conflict of interest.
The following faculty have provided no information regarding significant relationship with commercial supporters and/or discussion of investigational or non-EMEA/FDA approved (off-label) uses of drugs as of March 10, 2011.
Stephan Huijbregts